PRESS RELEASE published on 10/14/2024 at 16:00, 1 year 5 months ago Laxxon Medical to Present Innovative Oral GLP-1 Agonist with Multi-Compartment Micro-Tablet Form, Aiming to Enhance Patient Compliance for Special Patient Groups, at the 2024 BIO Europe Convention Laxxon Medical to showcase innovative oral GLP-1 Agonist micro-tablet at 2024 BIO Europe Convention, aiming to enhance patient compliance. Event aims to discover new partnerships Laxxon Medical Oral GLP-1 Agonist Patient Compliance Micro-tablet BIO Europe Convention
BRIEF published on 10/09/2024 at 20:06, 1 year 5 months ago Laxxon Medical to Present SPID® Technology at CPHI Milan 2024 Laxxon Medical Pharmaceutical Manufacturing SPID® Technology CGMP Printing Technology CPHI Milan 2024
BRIEF published on 10/09/2024 at 20:06, 1 year 5 months ago Laxxon Medical présentera la technologie SPID® au CPHI Milan 2024 Laxxon Medical Fabrication Pharmaceutique Technologie SPID® CPHI Milan 2024 Technologie D'impression CGMP
PRESS RELEASE published on 10/09/2024 at 20:01, 1 year 5 months ago Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy Laxxon Medical to showcase cGMP Printing Technology at CPHI Milan 2024, unveiling innovative oral drug delivery systems through SPID® Technology Laxxon Medical SPID® Technology CGMP Printing CPHI Milan Oral Drug Delivery
BRIEF published on 10/01/2024 at 15:05, 1 year 5 months ago Laxxon Medical et Adare Pharma Solutions annoncent une coopération conjointe pour la production de formes posologiques orales imprimées en 3D cGMP en Europe et aux États-Unis Production CGMP Laxxon Medical Adare Pharma Partenariat Pharmaceutique Médicaments Imprimés En 3D
BRIEF published on 10/01/2024 at 15:05, 1 year 5 months ago Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US CGMP Production Laxxon Medical Pharma Partnership 3D Printed Drugs Adare Pharma
PRESS RELEASE published on 10/01/2024 at 15:00, 1 year 5 months ago Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US Laxxon Medical & Adare Pharma Cooperate for cGMP 3D Printed Oral Dosage Forms production in Europe & US. Utilizing SPID® Technology by Laxxon & Adare's cGMP-certified facilities Drug Delivery Laxxon Medical 3D Printed Adare Pharma Solutions CGMP
BRIEF published on 05/22/2024 at 15:10, 1 year 10 months ago Laxxon Medical annonce le développement d'un actif GLP-1 oral non invasif Laxxon Medical Traitement De L'obésité Agoniste Du Récepteur GLP-1 Technologie SPID® Voie 505(b)2
BRIEF published on 05/22/2024 at 15:10, 1 year 10 months ago Laxxon Medical Announces Development of Non-Invasive Oral GLP-1 Asset Obesity Treatment Laxxon Medical GLP-1 Receptor Agonist SPID® Technology 505(b)2 Pathway
PRESS RELEASE published on 05/22/2024 at 15:05, 1 year 10 months ago Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market Laxxon Medical announces development program for LXM.2, a 3D printed oral GLP-1 receptor agonist for obesity treatment, offering an alternative to injections. Utilizes SPID® platform technology for enhanced bioavailability Obesity Treatment Laxxon Medical GLP-1 LXM.2 3D Printed
Published on 03/26/2026 at 16:20, 2 hours 35 minutes ago ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 13:00, 5 hours 55 minutes ago Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 5 hours 55 minutes ago GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 5 hours 56 minutes ago Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance
Published on 03/26/2026 at 18:29, 25 minutes ago IEVA GROUP: IEVA Group is listing on Euronext Growth® Paris to accelerate its growth and innovation strategy
Published on 03/26/2026 at 18:29, 25 minutes ago IEVA GROUP: IEVA Group entre en bourse sur Euronext Growth pour accélérer sa stratégie de croissance et d’innovation
Published on 03/26/2026 at 18:13, 42 minutes ago EQS-Adhoc: Allgeier SE: Allgeier meets its earnings guidance for 2025 and is strengthening its focus on AI-based platform technologies and software solutions
Published on 03/26/2026 at 18:00, 55 minutes ago E-PANGO: E-Pango retrouve son statut de fournisseur électrique
Published on 03/26/2026 at 18:17, 38 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:00, 55 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 55 minutes ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité